Bicycle Therapeutics Files 8-K on Financials
Ticker: BCYC · Form: 8-K · Filed: Aug 6, 2024 · CIK: 1761612
Sentiment: neutral
Topics: financial-reporting, sec-filing
Related Tickers: BCYC
TL;DR
BCYC filed an 8-K, expect financial updates soon.
AI Summary
On August 6, 2024, Bicycle Therapeutics plc filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as financial statements and exhibits. No specific financial figures or operational updates were detailed in the provided excerpt.
Why It Matters
This filing indicates Bicycle Therapeutics is providing updates on its financial performance and condition to the SEC, which is important for investors to monitor the company's health.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of financial information and does not contain any immediate negative or positive news.
Key Players & Entities
- Bicycle Therapeutics plc (company) — Registrant
- 0001761612 (company) — Central Index Key
- 2834 (company) — Standard Industrial Classification (Pharmaceutical Preparations)
- 001-38916 (company) — SEC File Number
FAQ
What specific financial results are being reported by Bicycle Therapeutics plc in this 8-K?
The provided excerpt of the 8-K filing indicates it concerns 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits', but does not detail specific financial figures.
When was this 8-K filing submitted to the SEC?
The filing was submitted on August 6, 2024.
What is the Standard Industrial Classification code for Bicycle Therapeutics plc?
The Standard Industrial Classification code for Bicycle Therapeutics plc is 2834, which corresponds to Pharmaceutical Preparations.
What is the Central Index Key (CIK) for Bicycle Therapeutics plc?
The Central Index Key for Bicycle Therapeutics plc is 0001761612.
What is the SEC file number for Bicycle Therapeutics plc?
The SEC file number for Bicycle Therapeutics plc is 001-38916.
Filing Stats: 559 words · 2 min read · ~2 pages · Grade level 12.7 · Accepted 2024-08-06 07:05:18
Filing Documents
- tm2420860d1_8k.htm (8-K) — 31KB
- tm2420860d1_ex99-1.htm (EX-99.1) — 61KB
- tm2420860d1_ex99-1img001.jpg (GRAPHIC) — 8KB
- 0001104659-24-086085.txt ( ) — 332KB
- bcyc-20240806.xsd (EX-101.SCH) — 3KB
- bcyc-20240806_def.xml (EX-101.DEF) — 26KB
- bcyc-20240806_lab.xml (EX-101.LAB) — 36KB
- bcyc-20240806_pre.xml (EX-101.PRE) — 25KB
- tm2420860d1_8k_htm.xml (XML) — 6KB
02
Item 2.02. Results of Operations and Financial Condition On August 6, 2024, Bicycle Therapeutics plc issued a press release announcing financial results for the fiscal quarter ended June 30, 2024 and other business highlights. A copy of the press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information contained in Item 2.02 in this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Financial Statements and Exhibits
Financial Statements and Exhibits (d) Exhibits Exhibit No. Description 99.1 Press Release issued August 6, 2024 104 Cover Page Interactive Data File (formatted in Inline XBRL)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: August 6, 2024 BICYCLE THERAPEUTICS PLC By: /s/ Alethia Young Name: Alethia Young Title: Chief Financial Officer